Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01253135 · ClinicalTrials.gov registry record · Phase 1
Study to Determine if Fibrin Affects the Ability of a Wound to Heal
A Phase 1 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT01253135 is a Phase 1 study that has completed, run by Healthpoint. The registered enrollment target is 40 participants.
The verdict
NCT01253135, a Phase 1 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the potential inhibitory effects of HP802-247 Vehicle on wound closure (healing), by comparing mean days to closure of superficial (partial-thickness) thermal wounds against similar wounds treated with white petrolatum.
Interventions
- OTHER White Petrolatum
- BIOLOGICAL Fibrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01253135
The ClinicalTrials.gov registry entry for NCT01253135 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which White Petrolatum is the first listed.
NCT01253135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01253135 about?
NCT01253135 is a clinical study titled "Study to Determine if Fibrin Affects the Ability of a Wound to Heal". The objective of this study is to evaluate the potential inhibitory effects of HP802-247 Vehicle on wound closure (healing), by comparing mean days to closure of superficial (partial-thickness) thermal wounds against similar wounds treated with white petrolatum.
What is the current status of trial NCT01253135?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2011-01. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01253135?
The interventions under investigation include: White Petrolatum (OTHER), Fibrin (BIOLOGICAL).
Who is sponsoring clinical trial NCT01253135?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.